- Report
- May 2024
- 138 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Clinical Trials
- June 2024
- 240 Pages
Global
From €2863EUR$3,000USD£2,399GBP
- Report
- January 2025
- 250 Pages
Global
From €4771EUR$4,999USD£3,997GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4724EUR$4,950USD£3,958GBP
- Report
- November 2023
- 432 Pages
Global
From €9067EUR$9,500USD£7,597GBP
- Report
- November 2023
- 230 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- May 2022
- 84 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- March 2022
- 40 Pages
Saudi Arabia
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 40 Pages
India
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2022
- 100 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- March 2022
- 80 Pages
Africa
From €1909EUR$2,000USD£1,599GBP
- Report
- March 2022
- 40 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 40 Pages
United States
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 40 Pages
South Korea
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 40 Pages
Russia
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 40 Pages
Japan
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 40 Pages
Ireland
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 40 Pages
Germany
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 40 Pages
France
From €1432EUR$1,500USD£1,199GBP

The Metastatic Prostate Cancer Drug market is a subset of the larger Prostate Cancer Drugs market. It is composed of drugs used to treat metastatic prostate cancer, which is cancer that has spread beyond the prostate to other parts of the body. These drugs are typically used in combination with other treatments such as surgery, radiation, and hormone therapy. Common drugs used to treat metastatic prostate cancer include abiraterone, enzalutamide, cabazitaxel, and docetaxel.
The Metastatic Prostate Cancer Drug market is highly competitive, with many companies offering treatments. Some of the major players in the market include Pfizer, Astellas Pharma, Sanofi, Merck, and Johnson & Johnson. Other companies include Bristol-Myers Squibb, Bayer, and Novartis. Show Less Read more